SCHEMBL5895767

SCHEMBL5895767

CCC(=O)C1C(=O)CCC12CCN(C(=O)O)CC2

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.32
▸ NAMPT P43490 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5896627 0.72 NAMPT (0.31) NAMPT
SCHEMBL5895498 0.71 TET3 (0.31) —
SCHEMBL16465708 0.71 NAMPT (0.36) NAMPT
SCHEMBL5895416 0.69 OPRM1 (0.33) OPRM1
SCHEMBL31081976 0.66 DDB1 (0.41) NAMPT
SCHEMBL5895020 0.66 GRIN2D (0.31) OPRM1
SCHEMBL21357446 0.65 ALDH1A1 (0.36) —
SCHEMBL17101518 0.65 IRAK4 (0.31) NAMPT
SCHEMBL29740655 0.65 NAMPT (0.31) NAMPT
SCHEMBL20472816 0.65 NAMPT (0.30) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091211-B2 Cyclopentyl modulators of chemokine receptor activity MERCK & CO., INC. (US) 2006-08-15 — — US disclosed
US-20050070609-A1 Cyclopentyl modulators of chemokine receptor activity MERCK SHARP & DOHME CORP. 2005-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070609-A1 Cyclopentyl modulators of chemokine receptor activity CCR5, CXCR1, ACKR3 OPRM1 262/4885NAMPT 2960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback